Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Biological Membrane-Penetrating Peptides: Computational Prediction and Applications
Ewerton Cristhian Lima de Oliveira, Kauê Santana da Costa, Paulo Sérgio Taube, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 32
Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
Chunmin Yang, Afsar Alam, Fahad A. Alhumaydhi, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3060-3060
Open Access | Times Cited: 18
Developing Dynamic Structure‐Based Pharmacophore and ML‐Trained QSAR Models for the Discovery of Novel Resistance‐Free RET Tyrosine Kinase Inhibitors Through Extensive MD Trajectories and NRI Analysis
Ehsan Sayyah, Lalehan Oktay, Huseyin Tunc, et al.
ChemMedChem (2024) Vol. 19, Iss. 12
Closed Access | Times Cited: 3
Molecular docking study of naturally derived flavonoids with antiapoptotic BCL-2 and BCL-XL proteins toward ovarian cancer treatment
Noraziah Nordin, Mohd Faiz Abd Ghani, Rozana Othman
Journal of Pharmacy And Bioallied Sciences (2020) Vol. 12, Iss. 6, pp. 676-676
Open Access | Times Cited: 26
Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines
Bilgesu Onur Sucu, Elif Beyza Koc, Özgecan Şavluğ İpek, et al.
Journal of Molecular Graphics and Modelling (2022) Vol. 113, pp. 108160-108160
Closed Access | Times Cited: 15
A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth
Seyma Calis, Berna Doğan, Serdar Durdağı, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Efficient, rapid, and high‐yield synthesis of aryl Schiff base derivatives and their in vitro and in silico inhibition studies of hCA I, hCA II, AChE, and BuChE
Musa Özil, Halis Türker Balaydın, Berna Doğan, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Open Access | Times Cited: 3
Molecular structures, DFT calculations, in silico molecular docking, predicted pharmacokinetics and biological activities of N-(quinolin-8-yl)-2- pyridine/pyrazine carboxamide compounds
Robert T. Kumah, Reinner O. Omondi, Gregory S. Smith, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139425-139425
Closed Access | Times Cited: 3
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study
Serdar Durdağı, Busecan Aksoydan, Berna Doğan, et al.
(2020)
Closed Access | Times Cited: 23
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of COVID-19 Main Protease: A Virtual Drug Repurposing Study
Serdar Durdağı, Busecan Aksoydan, Berna Doğan, et al.
(2020)
Open Access | Times Cited: 21
The Multistage Antimalarial Compound Calxinin Perturbates P. falciparum Ca2+ Homeostasis by Targeting a Unique Ion Channel
Yash Gupta, Neha Sharma, Snigdha Singh, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1371-1371
Open Access | Times Cited: 12
Predictive identification and design of potent inhibitors targeting resistance-inducing candidate genes from E. coli whole-genome sequences
Abdullahi Tunde Aborode, Neeraj Kumar, Christopher Busayo Olowosoke, et al.
Frontiers in Bioinformatics (2024) Vol. 4
Open Access | Times Cited: 2
Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model
Tarek Kanan, Duaa Kanan, Ebrahim Jaafar Al Shardoub, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 108, pp. 107968-107968
Open Access | Times Cited: 13
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combinedin silicoandin vitroStudy
Serdar Durdağı, Müge Didem Orhan, Busecan Aksoydan, et al.
Molecular Informatics (2021) Vol. 41, Iss. 2
Open Access | Times Cited: 13
Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches
Tufail Ali, Farah Anjum, Arunabh Choudhury, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 7, pp. 3459-3471
Closed Access | Times Cited: 5
Hybrid In Silico and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors
Kader Şahin, Müge Didem Orhan, Timuçin Avşar, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 3, pp. 1111-1123
Open Access | Times Cited: 12
Identifying Potential SOS1 Inhibitors via Virtual Screening of Multiple Small Molecule Libraries against KRAS‐SOS1 Interface
Saima Ikram, Ehsan Sayyah, Serdar Durdağı
ChemBioChem (2024) Vol. 25, Iss. 12
Closed Access | Times Cited: 1
Synthesis, Characterization, Biological Activity and Molecular Modeling Studies of Novel Aminoguanidine Derivatives
Nuriye Doğan, Sevtap Çağlar Yavuz, Kader Şahin, et al.
ChemistrySelect (2022) Vol. 7, Iss. 45
Closed Access | Times Cited: 7
Experimental and Computational Insights into Gangronema latifolium Leaf Compounds as GLP-1 Receptor Agonists
Ijeoma Akunna Duru, Uchechi E. Enenebeaku, Lynda Chioma Ngozi-Olehi, et al.
Chemistry Africa (2024) Vol. 7, Iss. 5, pp. 2581-2597
Closed Access | Times Cited: 1
Toward a Computational Ecotoxicity Assay
Natasha Kamerlin, Mickaël G. Delcey, Sergio Manzetti, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 8, pp. 3792-3803
Open Access | Times Cited: 10
In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPER
Loreley-A. Morelos-Garnica, Sonia Guzmán‐Velázquez, Itzia-I. Padilla-Martínez, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Design and Development of Cholinesterase Dual Inhibitors towards Alzheimer's Disease Treatment: A Focus on Recent Contributions from Computational and Theoretical Perspective
Fatima Y. Adeowo, Monsurat M. Lawal, Hezekiel M. Kumalo
ChemistrySelect (2020) Vol. 5, Iss. 44, pp. 14136-14152
Closed Access | Times Cited: 6
Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease
Lalehan Oktay, Ece Erdemoğlu, Ilayda Tolu, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 459-468
Open Access | Times Cited: 4
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study
Serdar Durdağı, Busecan Aksoydan, Berna Doğan, et al.
(2020)
Closed Access | Times Cited: 4
DIFFERENTIAL SCANNING CALORIMETRY: A SUITABLE METHODOLOGY TO PROBLEM THE BINDING PROPERTIES OF BCL-2 INHIBITORS
Bi̇rcan Di̇nç, Berna Doğan, Thomas Mavromoustakos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top